Alternate-Day Buprenorphine Administration. Phase I - 3

Summary

The purpose of this study is to determine if two times a subject's daily maintenance dose will hold for 48 hours without changes in agonist and antagonist effects.

Timeline

Start

1992-04

Primary completion

—

Completion

—

Publications

• Background Amass L, Bickel WK, Higgins ST, Badger GJ. Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sci. 1994;54(17):1215-28. doi: 10.1016/0024-3205(94)00848-5.

Drugs

Indications